Merus N.V.

Merus N.V. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Merus N.V. is not a good value stock. Merus N.V. is a mediocre stock to choose.
Log in to see more information.
Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development...
MRUS Fundamental Data by TradingView

News

TD Asset Management Inc Reduces Holdings in Merus (NASDAQ:MRUS)
TD Asset Management Inc Reduces Holdings in Merus (NASDAQ:MRUS)

Zolmax TD Asset Management Inc trimmed its stake in Merus (NASDAQ:MRUS - Free Report) by 15.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange...\n more…

Merus (NASDAQ:MRUS) Share Price Crosses Below Fifty Day Moving Average of $53.16
Merus (NASDAQ:MRUS) Share Price Crosses Below Fifty Day Moving Average of $53.16

Ticker Report Shares of Merus (NASDAQ:MRUS - Get Free Report) crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $53.16 and traded as low as $48.12. Merus...\n more…

Merus (NASDAQ:MRUS) Shares Gap Down to $51.77
Merus (NASDAQ:MRUS) Shares Gap Down to $51.77

Ticker Report Merus (NASDAQ:MRUS - Get Free Report) shares gapped down before the market opened on Friday . The stock had previously closed at $51.77, but opened at $50.66. Merus shares last traded at $50.48, with...\n more…

Merus, Foundation Medicine collaborate to advance treatments for NRG1+
Merus, Foundation Medicine collaborate to advance treatments for NRG1+

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Merus (NASDAQ:MRUS) Receives Consensus Recommendation of "Buy" from Analysts
Merus (NASDAQ:MRUS) Receives Consensus Recommendation of "Buy" from Analysts

Ticker Report Shares of Merus (NASDAQ:MRUS - Get Free Report) have been given an average rating of "Buy" by the twelve brokerages that are currently covering the company, MarketBeat.com reports. Ten research...\n more…

Vanguard Group Inc. Raises Stock Holdings in Merus (NASDAQ:MRUS)
Vanguard Group Inc. Raises Stock Holdings in Merus (NASDAQ:MRUS)

Zolmax Vanguard Group Inc. increased its stake in shares of Merus (NASDAQ:MRUS - Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and...\n more…